Darin Curtiss

Company: Beacon Therapeutics

Job title: Global Vice President - Clinical Development

Seminars:

Showcasing Phase 2 Clinical Data for Beacon Therapeutics Laru-Zova to Apply Learnings to Phase 3 Trials 9:30 am

Understanding the success of the subretinal administration of lara-zova to maximize delivery Analyzing phase 2 safety and efficacy results of DAWN trial to ensure quality takeaways for future clinical trials Discussing the pitfalls and side effects during the phase 2 trials to prevent similar problems during the next clinical trialRead more

day: Conference Day Two

Navigating Novel Ophthalmic Endpoint Development & Regulatory Validation to Accelerate Disease Therapeutic Approvals 10:00 am

Novel endpoint development and validation are major challenges in ophthalmic gene therapy, with regulatory acceptance crucial for approval. Traditional vision measures often fall short in rare, slow-progressing diseases, while patient-reported outcomes add variability. Join us in this workshop to identify effective endpoints and regulatory strategies to increase regulatory approval. Key Discussion Points: Navigating FDA’s RDEA…Read more

day: Pre-Conference Workshop Day